Workflow
Ocular Therapeutix(OCUL) - 2020 Q2 - Earnings Call Transcript

Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2020 Earnings Conference Call August 7, 2020 8:30 AM ET Company Participants Donald Notman - CFO Antony Mattessich - President, CEO & Director Michael Goldstein - Chief Medical Officer Conference Call Participants Joseph Catanzaro - Piper Sandler & Co. Yi Chen - H.C. Wainwright & Co. Dane Leone - Raymond James & Associates Jonathan Wolleben - JMP Securities Operator Good Morning, ladies and gentlemen. Thank you for standing by, and welcome to the Ocular Therapeutix ...